2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

By Rick A. Nishimura, Catherine M. Otto, R. Bonow, B. Carabello, John Erwin, R. Guyton, P. O'Gara, C. Ruiz, N. Skubas, P. Sorajja and 18 more. Journal of Thoracic and Cardiovascular Surgery, 2014

1,630 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine

View Paper: https://www.semanticscholar.org/paper/d2297f45aba9ddc4f2430f82c123c6e6c8cb7d1b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

Citations in the corpus

Challenges in Infective Endocarditis. (2017, methodology): “Strategies for the prevention and management of CDI are beyond the scope of the present review but are covered in detail by recent guidelines (142).”
Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. (2017, neutral): “, discordance between LV enlargement and Doppler measures of AR severity); or (3) discordance between clinical assessment and severity of AR by echocardiography(209); (4) patients with moderate or severe AR and suboptimal echocardiography for assessment of LV volumes and systolic function and measur”
2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014, background): “See the 2014 valvular heart disease CPG for the complete set of recommendations and specific definitions of disease severity (15) and Online Data Supplement 4 for additional information on valvular heart disease.”
The management of antithrombotic agents for patients undergoing GI endoscopy. (2016, background): “High-dose vitamin K should not be given routinely because this may create a hypercoagulable condition.(70) In the event of massive hemorrhage, hemodialysis can be used in patients receiving dabigatran (Pradaxa) but not for rivaroxaban (Xarelto), edoxaban (Savaysa), and apixaban (Eliquis) because of ”
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2017, methodology): “Please consult the full-text version of the 2014 VHD guideline (10) for text and evidence tables supporting the unchanged recommendations and for clinical areas not addressed in this focused update.”
Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis: 1-Year Results From the All-Comers NOTION Randomized Clinical Trial. (2015, background): “Previously, surgical aortic valve replacement (SAVR) was the only effective treatment, but after being introduced in 2002, transcatheter aortic valve replacement (TAVR) became an option for certain patients with severe symptomatic aortic valve stenosis that was considered inoperable or in patients a”
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2017, methodology): “Please consult the full-text version of the 2014 VHD guideline (10) for text and evidence tables supporting the unchanged recommendations and for clinical areas not addressed in this focused update.”
4D flow cardiovascular magnetic resonance consensus statement (2015, methodology): “Doppler echocardiography is often used to assess peak and mean velocities in the aorta and pulmonary artery for calculation of peak and mean pressure drops, known as gradients, via the simplified Bernoulli equation [7, 8].”
2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014, background): “See the 2014 valvular heart disease CPG for the complete set of recommendations and specific definitions of disease severity (15) and Online Data Supplement 4 for additional information on valvular heart disease.”